Addition of an NK1 receptor antagonist to standard antiemetic prophylaxis in patients with B-cell lymphoma receiving EPOCH.
Saved in:
| Title: | Addition of an NK1 receptor antagonist to standard antiemetic prophylaxis in patients with B-cell lymphoma receiving EPOCH. |
|---|---|
| Authors: | English S; Denver Health Medical Center, Denver, CO, USA., Lei M; Department of Pharmacy, Massachusetts General Hospital, Boston, MA, USA., Sorial M; Department of Pharmacy, Massachusetts General Hospital, Boston, MA, USA.; Department of Pharmacy, Dana Farber Cancer Institute, Boston, MA, USA., Roeland EJ; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA., Lou U; Department of Pharmacy, Massachusetts General Hospital, Boston, MA, USA. |
| Source: | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2026 Jul; Vol. 32 (5), pp. 771-778. Date of Electronic Publication: 2025 Jan 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1477-092X |
|---|---|
| DOI: | 10.1177/10781552241312097 |
